Correlation Between Quadratus Lumborum , Pelvic Floor Muscles and Diaphragm in Patients With Urinary Incontinence

Sponsor
Deraya University (Other)
Overall Status
Completed
CT.gov ID
NCT05803486
Collaborator
Omar Mohamed Mabrouk (Other), nehad mohamed reda (Other), mohamed ahmed (Other), mohamed ashraf (Other), doaa abdelnaseer (Other)
50
1
2.6
19.5

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate Correlation between quadratus lumborum , pelvic floor muscles and diaphragm in patients with urinary incontinence

Detailed Description

50 patients were distributed randomly into two groups. The first group measured ultrasound imaging for quadratus lumborum , pelvic floor muscles and diaphragm urinary incontinence female The second group measured ultrasound imaging for quadratus lumborum , pelvic floor muscles and diaphragm urinary incontinence female normal females.

Patients examined with medical ultrasound imaging .

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Correlation Between Quadratus Lumborum , Pelvic Floor Muscles and Diaphragm in Patients With Urinary Incontinence
Actual Study Start Date :
Jan 1, 2023
Actual Primary Completion Date :
Mar 20, 2023
Actual Study Completion Date :
Mar 20, 2023

Arms and Interventions

Arm Intervention/Treatment
experimental group

examined by ultrasound image to measure quadratus lumborum thickness, pelvic floor muscles force and diaphragm excursion in patients with urinary incontinence

control group

examined by ultrasound image to measure quadratus lumborum thickness, pelvic floor muscles force and diaphragm excursion in patients with urinary incontinence

Outcome Measures

Primary Outcome Measures

  1. Force of contraction of pelvic floor muscles [2 months]

    by ultrasound imaging, convex transducer was used at a frequency of 5 MHz for evaluating. Voluntary PFM contractions' force (strength) of all patients.

Secondary Outcome Measures

  1. diaphragm excursion [2 months]

    by ultrasound imaging, convex transducer was used at a frequency of 5 MHz for evaluating. Voluntary diaphragm excursion

Other Outcome Measures

  1. quadratus lumborum thickness [2 months]

    by ultrasound imaging, convex transducer was use quadratus lumborum thickness

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 40 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
    • Their ages varied from 30to 40years, their body mass index (BMI) was 25-30 kg/m2 and a number of parities ≤ three normal vaginal deliveries, at least two years and Subjects hadn't received drugs , urinary incontinence mild or modrate
Exclusion Criteria:
    1. History of spinal surgery or spinal fracture. 2. Volunteers with a history of a recto-vaginal or vesico-vaginal fistula, undiagnosed uterine bleeding urinary tract infection, diabetes, intrauterine device, chest and/or cardiac disease and using any drugs for urinary incontinence 3. Serious diseases, such as heart disease, kidney, liver diseases, gastric ulcer or duodenal ulcer.
  1. A history of bronchial asthma or any chest disease. 5. Uncontrolled diabetes or hypertension. 6. Patients with peacemaker or any metal implant on the treated area. 7. Cancer or patient with past history of tumor excision.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Deraya university Minya Egypt

Sponsors and Collaborators

  • Deraya University
  • Omar Mohamed Mabrouk
  • nehad mohamed reda
  • mohamed ahmed
  • mohamed ashraf
  • doaa abdelnaseer

Investigators

  • Principal Investigator: doaa A.Nasser abdelhady, Deraya University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Deraya University
ClinicalTrials.gov Identifier:
NCT05803486
Other Study ID Numbers:
  • 2\2023
First Posted:
Apr 7, 2023
Last Update Posted:
Apr 7, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 7, 2023